"10.1371_journal.pone.0144659","plos one","2015-12-08T00:00:00Z","Marianne Parent; Ariane Boudier; Julien Perrin; Claude Vigneron; Philippe Maincent; Nicolas Violle; Jean-François Bisson; Isabelle Lartaud; François Dupuis","CITHÉFOR EA 3452, Faculty of Pharmacy, Université de Lorraine, Nancy, France; INSERM U1116, Faculty of Medicine, Université de Lorraine, Vandœuvre-lès-Nancy, France; ETAP–Ethologie Appliquée, Research Centre in Pharmacology, Nutrition and Toxicology, Vandœuvre-lès-Nancy, France","Conceived and designed the experiments: MP AB FD JP NV. Performed the experiments: MP FD AB JP NV. Analyzed the data: MP FD AB JP NV JFB. Wrote the paper: MP AB IL CV PM FD.","The authors have the following interests: Nicolas Violle and Jean-François Bisson are employed by ETAP – Ethologie Appliquée. There is no commercial affiliation between ETAP-Lab and the other laboratory implicated in this work. ETAP-Lab does not claim any Industrial Property regarding GSNO effect and/or the tested formulations. ETAP-Lab and the other authors have no relationship of consultancy. ETAP-Lab will not claim patents regarding the tested products. As a preclinical CRO, ETAP-Lab does not develop health products and does not market such products. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2015","12","Marianne Parent","MP",9,TRUE,5,5,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
